Hans van Bruggen

Hans van Bruggen has a diverse work experience in the field of regulatory affairs and operations.

Hans currently serves as the General Manager at Celegence since 2022.

From 2016, they have been a Board Member at IRISS Forum (IRISS-Forum.org), where they actively contribute to improving ways of exchanging and sharing regulatory information.

In 2012, they joined B. Braun Group as an XEVMPD and IDMP service provider and Regulatory Affairs consultant. Their role involved implementing processes for collecting and maintaining XEVMPD and IDMP data.

Hans also worked as a Regulatory Operations service provider and Regulatory Affairs consultant at Santen, Intercept Pharmaceuticals, Astellas Pharma, Leadiant Biosciences Ltd, Nikkiso Belgium bvba, and Datwyler Sealing Solutions, where they provided support in regulatory operations and the maintenance of dossiers.

In 2006, they were a Presenter and Co-organizer at TOPRA, where they shared their knowledge and expertise in regulatory affairs.

Overall, Hans van Bruggen has gained extensive experience and expertise in regulatory affairs and operations, with a focus on data management, process implementation, and improving information exchange in the field.

Hans van Bruggen began their education in 1979 at OLAN, where they pursued a degree in Physiology Pharmacology. Hans completed their studies in 1983, earning a degree comparable to a Bachelor of Science (BSc). Later, in 1999, they enrolled at the University of Surrey and completed a Master of Science (MSc) in Pharmaceutical Medicine in 2003.